Cost-effectiveness watchdog NICE has recommended routine NHS use of two new therapies for women with advanced breast cancer – Gilead's Trodelvy and Novartis' Piqray – in England.
Bishal Gyawali, MD, PhD, and Sharon Batt, PhD, explore why overall survival continues to be the most patient-centric marker of clinical benefit.
It usually develops beneath the skin. While an armpit lump can be a symptom of breast cancer, it is not usually the first sign of breast cancer. Instead, the most common symptom of breast cancer is a ...
Though pink typically represents breast cancer awareness, the project is to support all cancers. “The initiative itself, Tough Enough to Wear Pink, it got started at National Finals Rodeo as a ...
A new site has been opened for breast cancer screening, available to women in the West Devon area ... “Patients will still be able to attend the mobile unit or University Hospitals Plymouth NHS Trust ...
The European Commission has approved Daiichi Sankyo and AstraZeneca's Enhertu as the first targeted therapy for HER2-low breast cancer ... the nod for use by the NHS in England after an earlier ...
Hopefully scientists are working on treatments to battle breast cancer that don't have hair loss ... isn't standard practice across the NHS. This needs to change. And medical teams must ensure ...
For Chris James, the Pink Sunday of the Donna Marathon brought a victorious homecoming. For Jamie Rogers, the chance to contribute to the fight against breast cancer stirred its own emotions.
The NHS has issued a warning about three potential symptoms of the UK's deadliest cancer, which could be easily mistaken for a common cold or other seasonal ailments. Cancer Research UK statistics ...
The singer tragically passed away on January 15 2025 aged 65 following a 20-year breast cancer battle and suffering from double pneumonia. And Linda's sister Coleen looked emotional as she ...
The NHS has warned of three potential symptoms of the UK’s deadliest cancer that could be mistaken for a cold or other seasonal illnesses. According to statistics from Cancer Research UK ...